NeuralCipher Research overview
The text below is the source article’s original abstract under a verified reuse license. cc by
Summary Alpha-synuclein (aSYN) is a small synaptic protein that is linked to Parkinson’s disease (PD) and other synucleinopathies. aSYN has been shown to undergo protein phase separation. We found that aSYN phase separation, in vitro and in cells, is regulated by vesicle-associated membrane protein 2 (VAMP2), the vesicular SNARE protein. We show that aSYN phase separation is promoted by C-terminal electrostatic interaction, which in cells is mediated via interaction with VAMP2. The condensate formation is specific for the R-SNARE VAMP2 and critically dependent on aSYN’s capacity to bind to lipid membranes. In vitro, the addition of VAMP2 decreases the saturation concentration of aSYN phase separation, which is mediated by its juxtamembrane domain. Our results delineate a molecular mechanism for the regulation of aSYN phase separation, indicating a potential switch from the dispersed to the phase-separated state during vesicle cycling. Highlights Alpha-synuclein phase separation is regulated by electrostatic interactions VAMP2 initiates alpha-synuclein condensation in cells Positive charges within the juxtamembrane domain of VAMP2 initiate alpha-synuclein phase separation in vitro Alpha-synuclein condensates nucleate on lipid membranes and assemble vesicular structures in cells
Scientific assessment
Research question
Assess the question within the original study’s scope.
Methods & sample
Check the source article for study design and sample details.
Key findings
An editorially approved findings summary is not yet published for this record.
Limitations
Generalizability, bias and clinical meaning require separate assessment.
Methods, samples and clinical conclusions are not inferred from bibliographic metadata.